Cusumano, P G <br/><br/>
European inter-institutional impact study of MammaPrint.  [electronic resource] 

 -  Breast (Edinburgh, Scotland)  Aug 2014 
 - 423-8 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1532-3080 
<br/><br/><label>Standard No.: </label>10.1016/j.breast.2014.02.011  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Agents, Hormonal--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant--methods<br/>Europe<br/>Female<br/>Gene Expression Profiling--methods<br/>Gene Expression Regulation, Neoplastic<br/>Humans<br/>Immunohistochemistry<br/>Middle Aged<br/>Patient Selection<br/>Prospective Studies<br/>Receptor, ErbB-2--metabolism<br/>Receptors, Estrogen--metabolism<br/>Receptors, Progesterone--metabolism<br/>Trastuzumab<br/>Young Adult